MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
PerkinElmer ROA Ratio 2011-2026 | PKI
Annual ROA Ratio PerkinElmer
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.98 | 2.18 | 5.11 | 6.29 | 1.6 | - | 3.48 | 3.98 | 5.48 | 5.1 | - | 3.82 | 4.24 | 0.2 | 11.96 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.96 | 0.2 | 4.26 |
Quarterly ROA Ratio PerkinElmer
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.9 | 2.26 | 2.23 | 1.35 | 1.42 | 0.75 | 0.59 | 4.21 | 4.83 | 5.38 | 6.39 | 3.07 | 7.85 | 8.09 | 9.64 | 12.78 | 10.57 | 12.29 | 11.54 | 5.17 | 6.15 | 4.48 | 3.47 | 3.48 | 3.69 | 4.07 | 4.09 | 3.98 | 2.11 | 2.33 | 4.61 | 4.8 | 7.12 | 6.97 | 5.14 | 5.64 | 5.36 | 5.37 | 5.05 | 3.56 | 4.31 | 3.97 | 3.99 | 3.82 | 4.77 | 4.76 | 4.25 | 4.24 | 2.14 | 1.88 | 2.03 | 1.79 | 11.33 | 11.65 | 11.61 | 11.79 | 1.08 | 0.83 | 0.75 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 12.78 | 0.59 | 5.0 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 168.22 | -3.26 % | $ 8.34 B |  USA |
 |
Agilent Technologies
A
|
11.3 | $ 114.84 | -0.55 % | $ 34.9 B | USA |
 |
Castle Biosciences
CSTL
|
3.43 | $ 24.73 | -0.44 % | $ 687 M | USA |
 |
Danaher Corporation
DHR
|
4.33 | $ 192.12 | 0.53 % | $ 137 B | USA |
 |
DexCom
DXCM
|
13.19 | $ 63.21 | 1.59 % | $ 24.7 B | USA |
 |
Aspira Women's Health
AWH
|
-234.24 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 16.42 | -2.38 % | $ 496 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M |  Israel |
 |
Guardant Health
GH
|
-20.67 | $ 89.66 | -4.44 % | $ 11.2 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 109.62 | -4.0 % | $ 9.04 B |  Irlanda |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 17.82 | -2.68 % | $ 950 M | USA |
 |
Illumina
ILMN
|
-19.4 | $ 127.74 | 0.28 % | $ 20.3 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 16.3 | 0.62 % | $ 175 M |  China |
 |
IQVIA Holdings
IQV
|
4.54 | $ 170.72 | -1.47 % | $ 29.3 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 274.46 | 0.27 % | $ 22.8 B | USA |
 |
Lantheus Holdings
LNTH
|
10.49 | $ 75.89 | -0.28 % | $ 5.12 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | USA |
 |
Medpace Holdings
MEDP
|
22.84 | $ 496.0 | -0.47 % | $ 14.3 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Mettler-Toledo International
MTD
|
23.41 | $ 1 266.63 | 0.53 % | $ 26.1 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-51.78 | $ 4.67 | -1.68 % | $ 432 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-182.35 | $ 4.74 | 1.07 % | $ 3.73 M | USA |
 |
NeoGenomics
NEO
|
-7.94 | $ 8.02 | 0.25 % | $ 1.03 B | USA |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 9.56 | 1.59 % | $ 2.07 B | USA |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
8.6 | $ 17.33 | 0.99 % | $ 388 M | USA |
 |
Natera
NTRA
|
-39.28 | $ 204.87 | -1.5 % | $ 20.2 B | USA |
|
Biodesix
BDSX
|
-44.15 | $ 15.36 | 1.92 % | $ 1.99 B | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Pacific Biosciences of California
PACB
|
-69.68 | $ 1.42 | 5.97 % | $ 426 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
10.73 | $ 27.2 | 0.33 % | $ 20 B |  Niderland |
 |
Precipio
PRPO
|
-1.7 | $ 25.98 | 1.64 % | $ 41.7 M | USA |
 |
Personalis
PSNL
|
-30.08 | $ 6.58 | - | $ 390 M | USA |
 |
RadNet
RDNT
|
-0.5 | $ 55.06 | 0.49 % | $ 4.14 B | USA |
 |
Senseonics Holdings
SENS
|
-54.73 | $ 6.69 | -3.04 % | $ 279 M | USA |
 |
Sotera Health Company
SHC
|
2.39 | $ 14.87 | -0.6 % | $ 4.22 B | USA |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Soleno Therapeutics
SLNO
|
3.71 | $ 52.25 | 32.31 % | $ 2.66 B | USA |
 |
Neuronetics
STIM
|
-27.55 | $ 1.76 | 15.79 % | $ 116 M | USA |
 |
Thermo Fisher Scientific
TMO
|
6.08 | $ 488.19 | -0.67 % | $ 184 B | USA |